A Comparison of preprandial mixed insulin given three times daily and basal-bolus insulin therapy started postoperatively on patients having coronary artery bypass graft surgery;Koroner arter bypass cerrahisi geçiren hastalarda 3'lü karışım ve 4'lü yoǧun i̇nsülin tedavilerinin karşılaştırılması

Marmara Medical Journal

Volumn 25, Issue 1, 2012, Pages 16-19

  Yazici, Dilek ^a   Taş, Serpil ^b   Emir, Hicran ^c   Sunar, Hasan ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b Kartal Kosuyolu Education and Research Hospital   (Turkey)

^c DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Basal bolus insulin therapy; Coronary artery bypass graft surgery; Premeal mixed insulin therapy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

EID: 84855739557     PISSN: 10191941     EISSN: 13099469     Source Type: Journal    
DOI: 10.5472/MMJ.2011.02134.1     Document Type: Article

References (12)

1. Knapik P, Cieśla D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg 2011;39:484-9. doi:10.1016/j.ejcts.2010.07.037
2. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2005;130:1144e1-1144e8. doi:10.1016/j.jtcvs.2005.05.049
3. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003;125:1007-1021. doi:10.1067/mtc.2003.181
4. Ingels C, Debaveye Y, Milants I, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J 2006;27:2716-2724. doi: 10.1093/eurheartj/ehi855
5. Bhullar J, Chung K, Trebble TM. Hyperglycaemia in post-surgical patients receiving oral, enteral and parenteral nutrition: is insulin sliding scale therapy sufficient? Proc Nutr Soc 2010;69:E226. doi: 10.1017/S0029665110001680
6. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
7. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963-72. doi: 10.2337/dc06-9912.
8. Garber AJ, Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006;8:58-66. doi: 10.1111/j.1463-1326.2005.00563.x
9. Jacober SJ, Scism-Bacon JL, Zagar AJ. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents. Diabetes Obes Metab 2006;8:448-55. doi: 10.1111/j.1463-1326.2006.00605.x
10. Kazda C, Hülstrunk H, Helsberg K, Langer F, Forst T, Hanefeld M. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy. J Diabetes Complications 2006;20:145-52. doi:10.1016/j.jdiacomp.2005.09.004.
11. Robbins DC, Beisswenger PJ, Ceriello A, et al. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels inpatients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Clin Ther 2007;29:2349-64.
12. Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S. Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oralagents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy. Diabetes Care 2008;31:20-5. doi: 10.2337/dc07-1122